Protein tyrosine phosphatase, nonreceptor type 22 (PTPN22), is an archetypal non-HLA autoimmunity gene. It is one of the most prominent genetic contributors to type 1 diabetes mellitus outside the HLA region, and prevalence of its risk variants is subject to enormous geographic variability. Here, we address the genetic background of patients with type 1 diabetes mellitus of Armenian descent. Armenia has a population that has been genetically isolated for 3000 years. We hypothesized that two PTPN22 polymorphisms, rs2476601 and rs1310182, are associated with type 1 diabetes mellitus in persons of Armenian descent. In this association study, we genotyped the allelic frequencies of two risk-associated PTPN22 variants in 96 patients with type 1 diabetes mellitus and 100 controls of Armenian descent. We subsequently examined the associations of PTPN22 variants with the manifestation of type 1 diabetes mellitus and its clinical characteristics. We found that the rs2476601 minor allele (c.1858T) frequency in the control population was very low (q = 0.015), and the trend toward increased frequency of c.1858CT heterozygotes among patients with type 1 diabetes mellitus was not significant (OR 3.34, 95% CI 0.88-12.75; χ2 test p > 0.05). The control population had a high frequency of the minor allele of rs1310182 (q = 0.375). The frequency of c.2054-852TC heterozygotes was significantly higher among the patients with type 1 diabetes mellitus (OR 2.39, 95% CI 1.35-4.24; χ2 test p < 0.001), as was the frequency of the T allele (OR 4.82, 95% CI 2.38-9.76; χ2 test p < 0.001). The rs2476601 c.1858CT genotype and the T allele correlated negatively with the insulin dose needed three to six months after diagnosis. The rs1310182 c.2054-852CC genotype was positively associated with higher HbA1c at diagnosis and 12 months after diagnosis. We have provided the first information on diabetes-associated polymorphisms in PTPN22 in a genetically isolated Armenian population. We found only a limited contribution of the prototypic gain-of-function PTPN22 polymorphism rs2476601. In contrast, we found an unexpectedly close association of type 1 diabetes mellitus with rs1310182.

3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Endocrinology Yerevan State Medical University after Mkhitar Heratsi Yerevan Armenia

See more in PubMed

Haber M, Mezzavilla M, Xue Y, Comas D, Gasparini P, Zalloua P, et al.. Genetic evidence for an origin of the Armenians from Bronze Age mixing of multiple populations. Eur J Hum Genet. 2016;24:931–936 doi: 10.1038/ejhg.2015.206 PubMed DOI PMC

Boyko EJ, Karuranga S, Magliano DJ, Saeedi P, Sun H. IDF Diabetes Atlas, 10th Edition. Brussels, International Diabetes Federation, 2022.

Stanford SM, Bottini NB. PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol. 2014;10:602–611. PubMed PMC

Vang T, Liu WH, Delacroix L, Wu S, Vasile S, Dahl R, et al.. LYP inhibits T cells activation when dissociated from CSK. Nat Chem Biol. 2012;8:437–446. PubMed PMC

Brownlie RJ, Miosge LA, Vassilakos D, Svensson LM, Cope A, Zamoyska R. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci Signal. 2012;5:ra87. PubMed PMC

Maine CJ, Hamilton-Williams EE, Cheung J, Stanford SM, Wicker LS, Sherman LA. PTPN22 alters the development of regulatory T cells in the thymus. J Immunol. 2012;188:5267–5275. PubMed PMC

Zheng W, She JX. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes. 54;2005:906. PubMed

Valta M, Gazali AM, Viisanen T, Ihantola E-L, Ekman I, Toppari J, et al.. Type 1 diabetes linked PTPN22 gene polymorphism is associated with the frequency of circulating regulatory T cells. Eur J Immunol. 2020;50:581–588. PubMed

Tizaoui K, Kim SH, Jeong GH, Kronbichler A, Lee KS, Shin JI. Association of PTPN22 1858C/T polymorphism with autoimmune diseases: a systematic review and Bayesian approach. J Clin Med. 2019;8:347. PubMed PMC

Totaro MC, Tolusso B, Napolioni V, Faustini F, Canestri S, Mannocci A, et al.. PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis. PLoS ONE. 2011;6:e24292. PubMed PMC

Pellegrino M, Ceccacci F, Petrini S, Scipioni A, De Santis S, Cappa M, et al.. Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes. Nanomedicine. 2019;18:371–379. PubMed

Arena A, Belcastro E, Ceccacci F, Petrini S, Conti LA, Pagliarosi O, et al.. Improvement of lipoplexes with a sialic acid mimetic to target the C1858T PTPN22 variant for immunotherapy in endocrine autoimmunity. Front Immunol. 2022;13:838331. PubMed PMC

Carlton VEH, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, et al.. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet. 2005;77:567–581. PubMed PMC

Taniyama M, Maruyama T, Tozaki T, Nakano Y, Ban Y. Association of PTPN22 haplotypes with type 1 diabetes in the Japanese population. Hum Immunol. 2010;71:795–798. PubMed

Ke X, Song S, Wang X, Shen Y, Kang H, Hong S. Association of single nucleotide polymorphisms of PTPN22 and Ctla4 genes with the risk of allergic rhinitis in a Chinese Han population. Hum Immunol. 2017;78:227–231. PubMed

Viken MK, Olsson M, Flåm ST, Førre O, Kvien TK, Thorsby E, et al.. The PTPN22 promoter polymorphis -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens. 2007;70:190–197. PubMed

Bahrami T, Soltani S, Moazzami K, Yekaninejad MS, Salmaninejad A, Soltaninejad E, et al.. Association of PTPN22 gene polymorphisms with susceptibility to juvenile idiopathic arthritis in Iranian population. Fetal Pediatr Pathol. 2017;36:42–48. PubMed

Bahrami T, Valilou SF, Sadr M, Soltani S, Salmaninejad A, Soltaninejad E, et al.. PTPN22 gene polymorphisms in pediatric systemic lupus erythematosus. Fetal Pediatr Pathol. 2020;39:13–20. PubMed

Sadr M, Moazzami B, Soleimanifar N, Elhamian N, Rezaei A, Daryani NE, et al.. Single nucleotide polymorphisms of PTPN22 gene in Iranian patients with ulcerative colitis. Fetal Pediatr Pathol. 2019;38:8–13. PubMed

Heneberg P, Kocková L, Čecháková M, Daňková P, Černá M. Autoimmunity-associated PTPN22 polymorphisms in latent autoimmune diabetes of the adult differ from those of type 1 diabetes patients. Int Arch Allergy Immunol. 2018;177:57–68. PubMed

Aflatounian M, Rezaei A, Sadr M, Saghazadeh A, Elhamian N, Sadeghi H, et al.. Association of PTPN22 single nucleotide polymorphisms with celiac disease. Fetal Pediatr Pathol. 2017;36:195–202. PubMed

Sadr M, Khalili N, Mohebbi B, Mosharmovahed B, Afradi P, Rezaei N. Association of PTPN22 single nucleotide polymorphisms with chronic spontaneous urticarial. Allergol Immunopathol (Madr). 2021:49:40–45. PubMed

Zoledziewska M, Perra C, Orrù V, Moi L, Frongia P, Congia M, et al.. Further evidence of a primary causal association of the PTPN22 620W variant with type 1 diabetes. Diabetes. 2008;57:229–234. PubMed

Abbasi F, Soltani S, Saghazadeh A, Soltaninejad E, Rezaei A, Bidoki AZ, et al.. PTPN22 single-nucleotide polymorphisms in Iranian patients with type 1 diabetes mellitus. Immunol Invest. 2017;46:409–418. PubMed

Heneberg P, Malá M, Yorifuji T, Gat-Yablonski G, Lebenthal Y, Tajima T, et al.. Low frequencies of autoimmunity-associated PTPN22 polymorphisms in MODY patients, including those transiently expressing islet cell autoantibodies. Int Arch Allergy Immunol. 2015;166:189–198. PubMed

Huang J-J, Qiu Y-R, Li H-X, Sun D-H, Yang J, Yang C-L. A PTPN22 promoter polymorphism -1123G>C is associated with RA pathogenesis in Chinese. Rheumatol Int. 2012;32:767–771. PubMed

Smith RL, Warren RB, Eyre S, Ke X, Young HS, Allen M, et al.. Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br J Dermatol. 2008;158:962–968. PubMed PMC

Brzoza Z, Grzeszczak W, Rogala B, Trautsolt W, Moczulski D. PTPN22 polymorphism presumably plays a role in the genetic background of chronic spontaneous autoreactive urticaria. Dermatology. 2012;224:340–345. PubMed

Zhang Q, Hou S, Jiang Z, Du L, Li F, Xiao X, et al.. No association of PTPN22 polymorphisms with susceptibility to ocular Behcet’s disease in two Chinese Han populations. PLoS ONE. 2012;7:e31230. PubMed PMC

Zhang Q, Qi J, Hou S, Du L, Yu H, Cao Q, et al.. A functional variant of PTPN22 confers risk for Vogt-Koyanagi-Harada syndrome but not for ankylosing spondylitis. PLoS ONE. 2014;9:e96943. PubMed PMC

Ban Y, Tozaki T, Taniyama M, Nakano Y, Ban Y, Ban Y, et al.. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid. 2010;20:893–899. doi: 10.1089/thy.2010.0104 PubMed DOI

Dullin R, Koch M, Sterneck M, Nashan B, Thude H. Association between a gain-of-function variant of PTPN22 and rejection in liver transplantation. Transplantation. 2015;99:431–437. PubMed

Thude H, Tiede P, Marget M, Peine S, Nashan B, Koch M. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene polymorphisms in liver transplant donors and impact on acute cellular liver transplant rejection. HLA. 2020;95:40–44. PubMed

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al.. 2. Classification and diagnosis of diabetes: Standards of care in diabetes 2023. Diabetes Care 2023;46:S19–S40. doi: 10.2337/dc23-S002 PubMed DOI PMC

Maple-Brown LJ, Ye C, Retnakaran R. Area-under-the-HbA1c curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial. Diabet Med. 2013;30:95–99. doi: 10.1111/dme.12004 PubMed DOI PMC

Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, et al.. Primer3 –new capabilities and interfaces. Nucleic Acids Res. 2012;40:e115. doi: 10.1093/nar/gks596 PubMed DOI PMC

Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al.. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36:337–338. doi: 10.1038/ng1323 PubMed DOI

Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol. 2011;28:2731–2739. doi: 10.1093/molbev/msr121 PubMed DOI PMC

Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett. 2011;585:3689–3698. PubMed

Kahles H, Ramos-Lopez E, Lange B, Zwermann O, Reincke M, Badenhoop K. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto’s thyroiditis or Addison’s disease in the German population. Eur J Endocrinol. 2005;153:895–899. PubMed

Cinek O, Hradsky O, Ahmedov G, Slavcev A, Kolouskova S, Kulich M, et al.. No independent role of the -1123G>C and +2740A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabet Res Clin Pract. 2007;76:297–303. PubMed

Blasetti A, Di Giulio C, Tumini S, Provenzano M, Rapino D, Comegna L, et al.. Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes. Pharmacogenomics J. 2017;17:186–191. PubMed

Pawłowicz M, Filiów R, Krzykowski G, Stanisławska-Sachadyn A, Morzuch L, Kulczycka J, et al.. Coincidence of PTPN22 c.1858CC and FCRL3 -169CC genotypes as a biomarker of preserved residual β-cell function in children with type 1 diabetes. Pediatr Diabetes. 2017;18:696–705. PubMed